Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety Study of A-101 Topical Solution for the Treatment of Common Warts

ClinicalTrials.gov ID: NCT03812510

Public ClinicalTrials.gov record NCT03812510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Open Label Safety Study of A-101 Topical Solution for the Treatment of Common Warts

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts

Study identification

NCT ID
NCT03812510
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aclaris Therapeutics, Inc.
Industry
Enrollment
426 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Year and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 6, 2019
Primary completion
Nov 26, 2019
Completion
Dec 19, 2019
Last update posted
Nov 22, 2020

2019

United States locations

U.S. sites
46
U.S. states
24
U.S. cities
43
Facility City State ZIP Site status
Aclaris Investigational Site Mobile Alabama 36608
Aclaris Investigational Site Glendale Arizona 85308
Aclaris Investigational Site Fort Smith Arkansas 72916
Aclaris Investigational Site Hot Springs Arkansas 71913
Aclaris Investigational Site Encinitas California 92024
Aclaris Investigational Site Fountain Valley California 92708
Aclaris Investigational Site San Diego California 92121
Aclaris Investigational Site San Diego California 92123
Aclaris Investigational Site Denver Colorado 80210
Aclaris Investigational Site Aventura Florida 33180
Aclaris Investigational Site Jacksonville Florida 32256
Aclaris Investigational Site Miami Florida 33134
Aclaris Investigational Site Miami Florida 33144
Aclaris Investigational Site Ocala Florida 34470
Aclaris Investigational Site Newnan Georgia 30263
Aclaris Investigational Site Indianapolis Indiana 46250
Aclaris Investigational Site New Albany Indiana 47150
Aclaris Investigational Site Louisville Kentucky 40241
Aclaris Investigational Site Rockville Maryland 20850
Aclaris Investigational Site Fridley Minnesota 55432
Aclaris Investigational Site Saint Joseph Missouri 64506
Aclaris Investigational Sites Omaha Nebraska 68144
Aclaris Investigational Site Las Vegas Nevada 89148
Aclaris Investigational Site Verona New Jersey 07044
Aclaris Investigational Site Rochester New York 14623
Aclaris Investigational Site Raleigh North Carolina 27612
Aclaris Investigational Site Beachwood Ohio 44122
Aclaris Investigational Site Bexley Ohio 43209
Aclaris Invesgational Site Broomall Pennsylvania 19008
Aclaris Investigational Site Fort Washington Pennsylvania 19034
Aclaris Investigational Site Upper Saint Clair Pennsylvania 15241
Aclaris Investigational Site Anderson South Carolina 29644
Aclaris Investigational Site Charleston South Carolina 29407
Aclaris Investigational Site Fountain Inn South Carolina 29644
Aclaris Investigational Site Knoxville Tennessee 37922
Aclaris Investigational Site Nashville Tennessee 37215
Aclaris Investigational Site Arlington Texas 76011
Aclaris Investigational Site Austin Texas 78759
Aclaris Investigational Site College Station Texas 77845
Aclaris Investigational Site Houston Texas 77598
Aclaris Investigational Site Pflugerville Texas 78660
Aclaris Investigational Site San Antonio Texas 78213
Aclaris Investigational Site Lynchburg Virginia 24501
Aclaris Investigational Site Norfolk Virginia 23502
Aclaris Investigational Site Norfolk Virginia 23507
Aclaris Investigational Site Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03812510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 22, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03812510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →